The result of nearly a decade of research, the late breaking research and ongoing scientific trials mark a breakthrough in antioxidant technology to prevent premature aging. When the skin is exposed to ultraviolet rays, Cyclobutane Pyrimidine Dimers [CPDs] are formed, also known as thymine dimers in the DNA molecule.
Moon Surgical Gets Second FDA Clearance, Covering its Commercial Maestro Robotic Surgery System
Moon Surgical announced the United States Food and Drug Administration (FDA) clearance for the commercial version of its unique Maestro surgical system.
Lupin Gets Tentative Approval from US FDA for Letermovir Tablets
Lupin has secured a tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Letermovir Tablets, 240 mg and 480 mg, to market a generic equivalent of Prevymis Tablets, 240 mg and 480 mg, of Merck Sharp & Dohme LLC.
Syngene Rolls Out New Platform for Enhanced Protein Production
Syngene International Ltd. has introduced its new protein production platform.
Kindeva Expands UK Facilities at Charnwood Campus
Kindeva Drug Delivery has expanded their Loughborough, UK, facilities at the Charnwood Campus Science Innovation and Technology Park.
UltraSight Partners with Mayo Clinic to Advance Next Generation Cardiac Care with AI
UltraSight is collaborating with Mayo Clinic on a new endeavor with the goal of enhancing cardiac care by harnessing the power of AI in point-of-care ultrasound.
Bionova Scientific to Expand New Plasmid DNA GMP Facility
Bionova Scientific has decided to expand into plasmid DNA (pDNA) production.
PhoreMost Join Hands with Boehringer Ingelheim
PhoreMost Ltd. has made a multi-project target discovery collaboration with Boehringer Ingelheim.
Rhythm Pharma Presents Patient-Reported Experiences with Hyperphagia at ENDO 2024
Rhythm Pharmaceuticals, Inc. has presented the first patient and caregiver reported experiences from qualitative interviews following the completion of a Phase 2 trial.
Aurigene Opens its Biologics Facility in Hyderabad
Aurigene Pharmaceutical Services has inaugurated its biologics facility spread across 70,000 sq.ft. in Genome Valley, a bio cluster, located in Hyderabad, India.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy